Skip to content

Effects of Amantadine on Postoperative Cognitive Dysfunction

Effects of Amantadine on Postoperative Cognitive Dysfunction in Elderly Patients With Elective Abdominal Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03527134
Enrollment
390
Registered
2018-05-17
Start date
2019-04-30
Completion date
2021-10-31
Last updated
2019-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction

Brief summary

Post-operative cognitive dysfunction (POCD) is a fairly well-documented clinical phenomenon. Investigators will determine whether amantadine can reduce the occurrence of POCD in elderly patients with major abdominal surgery.

Detailed description

Patients who are 60 years old or older for laparoscopic abdominal surgery will be randomly assigned into two groups: 1) no-treatment group, and 2) amantadine-treated group. Each group will have 150 patients. In addition, investigators will need 90 subjects in the control group. The data of these control subjects will be used to normalize the data of the two studied groups to diagnose POCD. The subjects in control groups will also be elderly but without the exposure to anesthesia and surgery.

Interventions

DRUGAmantadine

patients will receive amantadine 100 mg by month 2 h before the induction of general anesthesia and then 100 mg each time, three times per day for 5 days.

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
CollaboratorOTHER
Sun Yat-sen University
CollaboratorOTHER
Zhiyi Zuo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

Two groups: one with amantadine treatment and the other with amantadine treatment.

Eligibility

Sex/Gender
ALL
Age
60 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

1. major elective gynecological, prostate or bladder surgery patients who are ≥ 60 years old. 2. the surgery is laparoscopic surgery and is expected to last for ≥ 2 hours under general anesthesia and the patient will stay in hospital for at least 7 days after surgery. 3. lack of serious hearing and vision impairment and be able to read so that neurobehavioral tests can be performed.

Exclusion criteria

1. Patients are not expected to be alive for longer than 3 months. 2. Mini-mental State Examination (MMSE) \[18\] score ≤ 23. 3. history of dementia, psychiatric illness or any diseases of central nervous system. 4. current use of sedatives or antidepressant. 5. alcoholism and drug dependence. 6. patients previously included in this study (for patients who have second intra-abdominal surgery during the study period). 7. difficult to follow up or patients with poor compliance. 8. uncontrolled hypertension (\> 180/100 mmHg)

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with postoperative cognitive dysfunction (POCD) (POCD is a composite outcome measure)At 7 days after the surgeryThe existence of POCD will be determined by Visual Verbal Learning Test based on the Rey's Auditory Recall of words, Concept Shifting Test, Stroop Color Word Interference Test and Letter-Digit Coding based on the Symbol Digit Substitution Test

Secondary

MeasureTime frameDescription
Number of patients with postoperative cognitive dysfunction (POCD) (POCD is a composite outcome measure)At 3 months after the surgeryThe existence of POCD will be determined by Visual Verbal Learning Test based on the Rey's Auditory Recall of words, Concept Shifting Test, Stroop Color Word Interference Test and Letter-Digit Coding based on the Symbol Digit Substitution Test
Time for bowel function return after surgeryup to 2 weeks after the surgery
Degree of increase of stress hormoneUp to 5 days after the surgeryAdrenocorticotropic Hormone
Length of hospital stayUp to 3 months after the surgery
Degree of change in growth factorUp to 5 days after the surgeryBrain-derived neurotrophic factor and glial cell derived neurotrophic factor

Countries

China

Contacts

Primary ContactYujuan Li, MD
yujuan_04@hotmail.com15918734156

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026